Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS
IST:KRDMD.E
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Teladoc Health Inc
NYSE:TDOC
|
Health Care
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
Health Care
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
Lockheed Martin Corp
NYSE:LMT
|
Aerospace & Defense
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
Pharmaceuticals
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Micron Technology Inc
NASDAQ:MU
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.08
32.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Teladoc Health Inc
NYSE:TDOC
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Hims & Hers Health Inc
NYSE:HIMS
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Micron Technology Inc
NASDAQ:MU
|
US |
This alert will be permanently deleted.
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS
Cash Flow Statement
Cash Flow Statement
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
61
|
724
|
1 749
|
2 594
|
3 853
|
4 522
|
4 722
|
4 109
|
2 174
|
1 645
|
1 084
|
1 033
|
1 588
|
115
|
(1 441)
|
|
| Depreciation & Amortization |
225
|
238
|
237
|
243
|
245
|
271
|
295
|
318
|
1 506
|
360
|
360
|
392
|
1 623
|
1 984
|
2 435
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
497
|
404
|
755
|
859
|
836
|
894
|
884
|
622
|
3 720
|
777
|
755
|
1 005
|
(468)
|
123
|
1 566
|
|
| Cash Taxes Paid |
4
|
11
|
93
|
372
|
582
|
909
|
1 004
|
962
|
1 047
|
432
|
477
|
297
|
276
|
455
|
320
|
|
| Cash Interest Paid |
115
|
99
|
115
|
92
|
280
|
284
|
272
|
297
|
182
|
101
|
145
|
180
|
242
|
242
|
231
|
|
| Change in Working Capital |
909
|
781
|
241
|
118
|
142
|
1 209
|
(600)
|
(2 082)
|
(14 515)
|
(3 269)
|
(4 240)
|
(4 654)
|
1 827
|
(1 012)
|
(3 013)
|
|
| Cash from Operating Activities |
1 691
N/A
|
2 147
+27%
|
2 982
+39%
|
3 813
+28%
|
5 077
+33%
|
6 897
+36%
|
5 301
-23%
|
2 967
-44%
|
(8 182)
N/A
|
(487)
+94%
|
(2 040)
-319%
|
(2 225)
-9%
|
4 570
N/A
|
1 209
-74%
|
(452)
N/A
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(343)
|
(315)
|
(237)
|
(246)
|
(299)
|
(403)
|
(539)
|
(687)
|
(2 085)
|
(1 347)
|
(1 388)
|
(1 499)
|
(2 391)
|
(2 200)
|
(2 249)
|
|
| Other Items |
51
|
169
|
123
|
78
|
144
|
342
|
32
|
167
|
899
|
(353)
|
47
|
97
|
991
|
1 477
|
1 292
|
|
| Cash from Investing Activities |
(292)
N/A
|
(146)
+50%
|
(113)
+22%
|
(168)
-48%
|
(155)
+8%
|
(61)
+61%
|
(506)
-731%
|
(520)
-3%
|
(1 186)
-128%
|
(1 700)
-43%
|
(1 341)
+21%
|
(1 402)
-4%
|
(1 400)
+0%
|
(724)
+48%
|
(956)
-32%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 048
|
0
|
0
|
0
|
(138)
|
0
|
0
|
|
| Net Issuance of Debt |
(222)
|
(255)
|
(919)
|
(1 015)
|
(735)
|
(910)
|
(1 011)
|
(1 111)
|
(1 356)
|
(792)
|
(801)
|
373
|
(1 387)
|
(1 690)
|
(1 261)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
(451)
|
(451)
|
(2 053)
|
0
|
(568)
|
(568)
|
(358)
|
0
|
0
|
|
| Other |
49
|
(37)
|
(21)
|
(56)
|
(270)
|
(158)
|
(162)
|
(74)
|
346
|
202
|
214
|
219
|
353
|
375
|
380
|
|
| Cash from Financing Activities |
(173)
N/A
|
(293)
-69%
|
(940)
-221%
|
(1 071)
-14%
|
(1 005)
+6%
|
(1 068)
-6%
|
(1 624)
-52%
|
(1 635)
-1%
|
(2 015)
-23%
|
(855)
+58%
|
(520)
+39%
|
660
N/A
|
(1 529)
N/A
|
(1 811)
-18%
|
(1 259)
+30%
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
1 225
N/A
|
1 709
+39%
|
1 928
+13%
|
2 574
+33%
|
3 917
+52%
|
5 768
+47%
|
3 170
-45%
|
811
-74%
|
(11 383)
N/A
|
(3 042)
+73%
|
(3 901)
-28%
|
(2 966)
+24%
|
1 640
N/A
|
(1 325)
N/A
|
(2 668)
-101%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
1 348
N/A
|
1 833
+36%
|
2 745
+50%
|
3 566
+30%
|
4 778
+34%
|
6 494
+36%
|
4 762
-27%
|
2 280
-52%
|
(10 267)
N/A
|
(1 834)
+82%
|
(3 428)
-87%
|
(3 724)
-9%
|
2 178
N/A
|
(991)
N/A
|
(2 701)
-172%
|
|
You don't have any saved screeners yet
